Immediate or Delayed Breast Reconstruction After Radical Mastectomy in Breast Cancer Patients: Does It Make a Difference in the Quality of Life

2011 ◽  
Vol 31 (3) ◽  
pp. 664-673 ◽  
Author(s):  
Sonay BALTACI GÖKTAŞ ◽  
Bahadır Mahmut GÜLLÜOĞLU ◽  
Deniz ŞELİMEN
The Breast ◽  
2005 ◽  
Vol 14 (3) ◽  
pp. 201-208 ◽  
Author(s):  
Elisabeth Edström Elder ◽  
Yvonne Brandberg ◽  
Tina Björklund ◽  
Richard Rylander ◽  
Jakob Lagergren ◽  
...  

2008 ◽  
Vol 6 (7) ◽  
pp. 89-90 ◽  
Author(s):  
M.A. Chang ◽  
J.S. Lee ◽  
S.H. Ann ◽  
K.S. Park ◽  
B.K. Gu ◽  
...  

2021 ◽  
Author(s):  
Ying Gao ◽  
Yao Wang ◽  
Hongchu Chen ◽  
Ran Yan ◽  
Tao Liu ◽  
...  

Abstract BackgroundRadical mastectomy may lead to suppression of cellular immune function in patients with malignant tumors, and affect the quality of life (QOL) of patients. Immune suppression is a common cause of complications and adverse reactions in adjuvant therapy after radical mastectomy of breast cancer. Currently, there are few proven effective treatments for immune suppression. Therefore, it’s necessary to develop a new treatment method. Press needle is widely used in clinical practice. However, there have been relatively few studies that evaluate the effects of press needle on postoperative immune function. The aim of the present study is to assess the effects of press needle on immune function and QOL in female breast cancer patients undergoing radical mastectomy.MethodsThis study will be a single-center, randomized and single-blinded trial. 78 eligible patients will be randomized in a ratio of 1:1 to the press needle group or the sham press needle group. During the treatment phase, patients will undergo five times weekly of verum press needle or sham press needle for 2 weeks, and then they will be followed-up for 2 weeks. The primary outcome measures will be the peripheral blood levels of CD8+, CD4+, CD3+, and CD4+/CD8+ T cells. The secondary outcome measures will be the changes of patients’ QOL, evaluated by the Karnofsky Performance Scale (KPS) score and the EORTC core quality of life questionnaire (EORTC QLQ-C30). Safety and adverse events will be assessed at each visit. DiscussionThe results of this on-going study will provide clinical evidence for the effects and safety of press needle on immune function and QOL in patients after breast cancer resection compared with sham press needle.Trial registrationChinese Clinical Trial Registry, ChiCTR2000040100. Registered on 21 November 2020.


2019 ◽  
Vol 300 (2) ◽  
pp. 409-420 ◽  
Author(s):  
Moritz Hamann ◽  
Melanie Brunnbauer ◽  
Heike Scheithauer ◽  
Ulrich Hamann ◽  
Michael Braun ◽  
...  

Gland Surgery ◽  
2020 ◽  
Vol 9 (3) ◽  
pp. 767-774
Author(s):  
Xiaoqing Wang ◽  
Kepeng Zhu ◽  
Liang Ren ◽  
Hanbing Li ◽  
Shuai Lin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document